0001415889-22-009867.txt : 20220922
0001415889-22-009867.hdr.sgml : 20220922
20220922163813
ACCESSION NUMBER: 0001415889-22-009867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220920
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boulding Mark Elliott
CENTRAL INDEX KEY: 0001578852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 221259628
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-09222022_010902.xml
X0306
4
2022-09-20
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001578852
Boulding Mark Elliott
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
false
true
false
false
EXEC. VP AND CLO
Common Stock
2022-09-20
4
M
0
876
30.86
A
61986
D
Common Stock
2022-09-20
4
S
0
876
55
D
61110
D
Common Stock
2022-09-20
4
M
0
300
30.86
A
61410
D
Common Stock
2022-09-20
4
S
0
300
55
D
61110
D
Stock Option (Right to Buy)
30.86
2022-09-20
4
M
0
876
30.86
D
2026-01-03
Common Stock
70000
69124
D
Stock Option (Right to Buy)
30.86
2022-09-20
4
M
0
300
30.86
D
2026-01-03
Common Stock
69124
68824
D
Stock Option (Right to Buy)
51
2025-01-01
Common Stock
85600
85600
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
72500
72500
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
17500
17500
D
Stock Option (Right to Buy)
51.16
2030-01-28
Common Stock
59500
59500
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
59500
59500
D
Stock Option (Right to Buy)
38.10
2032-01-06
Common Stock
54000
54000
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 2, 2021.
Currently exercisable.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
/s/ Avraham S. Adler, Attorney-in-Fact
2022-09-22